Neutralizing antibodies against the SARS-CoV-2 Omicron variant following two CoronaVac vaccinations and a Pfizer/BioNTech mRNA vaccine booster. [Editorial] (2022)
- Authors:
- USP affiliated authors: MENDOZA, TÂNIA REGINA TOZETTO - FM ; CORRÊA, MARIA CASSIA JACINTHO MENDES - FM
- Unidade: FM
- DOI: 10.1590/S1678-9946202264043
- Subjects: ANTICORPOS; VACINAÇÃO; COVID-19
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Revista do instituto de medicina tropical de sao paulo
- ISSN: 0036-4665
- Volume/Número/Paginação/Ano: v. 64, article ID e43, 3p, 2022
- Status:
- Artigo publicado em periódico de acesso aberto (Gold Open Access)
- Versão do Documento:
- Versão publicada (Published version)
- Acessar versão aberta:
-
ABNT
SILVA JUNIOR, Almir Ribeiro da et al. Neutralizing antibodies against the SARS-CoV-2 Omicron variant following two CoronaVac vaccinations and a Pfizer/BioNTech mRNA vaccine booster. [Editorial]. Revista do instituto de medicina tropical de sao paulo. São Paulo: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://doi.org/10.1590/S1678-9946202264043. Acesso em: 29 mar. 2026. , 2022 -
APA
Silva Junior, A. R. da, Villas-Boas, L. S., Paula, A. V. de, Mendoza, T. R. T., Honorato, L., Witkin, S. S., & Correa, M. C. J. M. (2022). Neutralizing antibodies against the SARS-CoV-2 Omicron variant following two CoronaVac vaccinations and a Pfizer/BioNTech mRNA vaccine booster. [Editorial]. Revista do instituto de medicina tropical de sao paulo. São Paulo: Faculdade de Medicina, Universidade de São Paulo. doi:10.1590/S1678-9946202264043 -
NLM
Silva Junior AR da, Villas-Boas LS, Paula AV de, Mendoza TRT, Honorato L, Witkin SS, Correa MCJM. Neutralizing antibodies against the SARS-CoV-2 Omicron variant following two CoronaVac vaccinations and a Pfizer/BioNTech mRNA vaccine booster. [Editorial] [Internet]. Revista do instituto de medicina tropical de sao paulo. 2022 ; 64[citado 2026 mar. 29 ] Available from: https://doi.org/10.1590/S1678-9946202264043 -
Vancouver
Silva Junior AR da, Villas-Boas LS, Paula AV de, Mendoza TRT, Honorato L, Witkin SS, Correa MCJM. Neutralizing antibodies against the SARS-CoV-2 Omicron variant following two CoronaVac vaccinations and a Pfizer/BioNTech mRNA vaccine booster. [Editorial] [Internet]. Revista do instituto de medicina tropical de sao paulo. 2022 ; 64[citado 2026 mar. 29 ] Available from: https://doi.org/10.1590/S1678-9946202264043 - The vaginal Torquetenovirus titer varies with vaginal microbiota composition in pregnant women
- Generation of neutralizing antibodies against Omicron, Gamma and Delta SARS-CoV-2 variants following CoronaVac vaccination
- Evaluation of enterovirus concentration, species identification, and cerebrospinal fluid parameters in patients of different ages with aseptic meningitis in Sao Paulo, Brazil
- Association between torquetenovirus in vaginal secretions and infertility: an exploratory metagenomic analysis
- Impact of the Covid-19 pandemic on cervical cancer screening in São Paulo State, Brazil
- Association between development of severe COVID-19 and a polymorphism in the CIAS1 gene that codes for an inflammasome component
- Absence of neutralizing antibodies against the Omicron SARS-CoV-2 variant in convalescent sera from individuals infected with the ancestral SARS-CoV-2 virus or its Gamma variant
- SARS-CoV-2 shedding, infectivity, and evolution in an immunocompromised adult patient
- Herpes viroses EBV, HHV-8, HHv-6, e HHV-7
- Detailed characterization of Redondovirus in saliva of SARS-CoV-2-infected individuals in Sao Paulo, Brazil
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
Por se tratar de integração com serviço externo, podem existir diferentes versões do trabalho (como preprints ou postprints), que podem diferir da versão publicada.
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
